ILLUMINATION INNOVATION TRANSFORMATION
Live / Applied — Second extension granted (statement of use) (as of 17 Sept 2025)
What this means for you
Not registered yet, but its 18 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98140047
- Mark type
- Stylized text
- Filed
- 18 Aug 2023
- Published for opposition
- 03 Sept 2024
- Attorney of record
- J. Derek Mason
Goods and services
- Class 001 — Chemicals: Chemical additives for altering color in cosmetic preparations; substances in the nature of chemicals for use in solar cells and photovoltaic cells
- Class 002 — Paints: Particulate energy converting additives for altering color in paint, pigment and colorant preparations; paint preparations in the nature of paints containing particulate energy converting additives for altering color; pigment preparations in the nature of pigments containing particulate energy converting additives for altering color; colorant preparations in the nature of colorants containing particulate energy converting additives for altering color
- Class 003 — Cosmetics and cleaning preparations: Additives for altering color in cosmetic preparations, namely, coloring preparations and non-medicated skin care preparations; cosmetic preparations
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for biological tissue regeneration; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of brain disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune disease and disorders; pharmaceutical agents for treating a disease, condition, or disorder of the tissues of a subject by detecting and triggering biophotons; pharmaceutical agents for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intercellular communication; pharmaceutical agents for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intracellular communication; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering biophotons; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intercellular communication; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intracellular communication; preparations for sanitization and remediation of air supply, water supply, and biological materials for medical purposes
- Class 009 — Scientific and electric apparatus: Energy storage systems comprised of solar cells, photovoltaic cells and modules and any combination thereof; optical fibers for light or color transmission; optical communication networks comprised of optical fibers
- Class 010 — Medical apparatus: Medical device for detection of biophotons; medical device for detection of intercellular communication; medical device for detection of intracellular communication; medical device for treating a disease, condition and disorder by detection of intercellular communication; medical device for treating a disease, condition and disorder by detection of intracellular communication; medical device for triggering of biophotons; medical device for detection of intercellular communication; medical device for triggering of intracellular communication; medical device for treating a disease, condition and disorder by triggering of intercellular communication; medical device for treating a disease, condition and disorder by triggering of intracellular communication
Owner
- Immunolight, LLC, Detroit, MI, US
- Immunolight, LLC, Detroit, MI, US
Prosecution history
- 18 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Sept 2025 — SOU EXTENSION 2 GRANTED
- 17 Sept 2025 — SOU EXTENSION 2 FILED
- 17 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2025 — SOU EXTENSION 1 GRANTED
- 24 Apr 2025 — SOU EXTENSION 1 FILED
- 24 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2024 — PUBLISHED FOR OPPOSITION
- 14 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE